γ-Glutamyl transpeptidase-dependent iron reduction and LDL oxidation - A potential mechanism in atherosclerosis

Journal of Investigative Medicine

Volumn 47, Issue 3, 1999, Pages 151-160

  Paolicchi, Aldo ^a   Minotti, Giorgio ^b   Tonarelli, Patrizia ^a   Tongiani, Roberto ^a   De Cesare, Domenico ^b   Mezzetti, Andrea ^b   Dominici, Silvia ^d   Comporti, Mario ^d   Pompella, Alfonso ^c  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d Univ of Siena School of Medicine ^*

Author keywords

Atherosclerosis; Glutathione; Iron reduction; LDL oxidation; glutamyl transpeptidase

Indexed keywords

BATHOPHENANTHROLINE DISULFONIC ACID; CATALASE; CHELATING AGENT; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; IRON; LOW DENSITY LIPOPROTEIN; PHENANTHROLINE DERIVATIVE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; CELL STRAIN U937; CHEMISTRY; ENZYME IMMUNOASSAY; ENZYMOLOGY; FOAM CELL; HUMAN; LIPID PEROXIDATION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; ARTERIOSCLEROSIS; CATALASE; CHELATING AGENTS; FOAM CELLS; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE; HUMANS; IMMUNOENZYME TECHNIQUES; IRON; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PHENANTHROLINES; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; U937 CELLS;

EID: 0033090084     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Rad Biol Med 1996;20:707-27.
2. Minotti G. Sources and role of iron in lipid peroxidation. Chem Res Toxicol 1993;6:134-46.
3. Minotti G. Mordente A, Cavaliere AF. Metal ions, freee radicals and disease. In: G Berthon, ed. Handbook of metal ligand interactions in biological fluids. New York: Marcel Dekker Publishing Co., 1995:962-75.
4. Lynch SM, Frei B. Reduction of copper, but not iron, by human low density lipoprotein. J Biol Chem 1995;270:5158-63.
5. Lynch SM, Frei B. Mechanisms of copper- and iron-dependent oxidative modification of low density lipoprotein. J Lipid Res 1993;34:1745-53.
6. Parthasarathy S. Oxidation of low density lipoprotein by thiol compounds leads to its recognition by the acetyl-LDL receptor. Biochim Biophys Acta 1987;917:337-40.
7. Heinecke JW, Suzuki L, Rosen H. Chait A. The role of sulfur containing aminoacids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J Biol Chem 1987;262:10098-103.
8. Heinecke JW, Kawamura N. Suzuki L, Chait A. Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanisms. J Lipid Res 1993;34:2051-61.
9. Sparrow CP, Olszewski J. Cellular oxidation of LDL is caused by thiol production in media containing transition metal ions. J Lipid Res 1993;34:1219-28.
10. Hirano K, Ogihara T. Miki M, Yasuda H, Tamai H. Kawamura N. Mino M. Homocysteine induces iron-catalyzed lipid peroxidation of low-density lipoprotein that is prevented by alpha-tocopherol. Free Rad Res 1994;21:267-76.
11. Tien M, Bucher JR, Aust SD. Thiol-dependent lipid peroxidation. Biochem Biophys Res Commun 1982;107:279-85.
12. Griffith OW, Meister A. Glutathione: interorgan translocation, turnover, and metabolism. Proc Natl Acad Sci USA 1979;76:5606-10.
13. 2-induced injury by 2,3-dimethoxy-1,4-naphthoquinone. Free Rad Biol Med 1993;15:57-67.
14. Spear N. Aust SD. Thiol-mediated NTA-Fe(III) reduction and lipid peroxidation. Arch Biochem Biophys 1994;312:198-202.
15. Stark A-A, Zeiger E, Pagano DA. Glutathione metabolism by γ-glutamyl transpeptidase leads to lipid peroxidation: characterization of the system and relevance to hepatocarcinogenesis. Carcinogenesis 1993;14:183-9.
16. Paolicchi A, Tongiani R. Tonarelli P. Comporti M, Pompella A. Gamma-glutamyl transpeptidase-dependent lipid peroxidation in isolated hepatocytes and HepG2 hepatoma cells. Free Rad Biol Med 1997;22:853-60.
17. Paolicchi A, Minotti G. Tonarelli P. Tongiani R. De Cesare D, Mezzetti A, Comporti M, Pompella A. γ-Glutamyl transpeptidase-dependent iron reduction and LDL oxidation: characterization of a novel mechanism in atherogenesis. J Invest Med 1997;45:270A.
18. Huseby NE, and Strömme JH. Practical points regarding routine determination of γ-glutamyl transferase (γ-GT) in serum with a kinetic method at 37°C. Scand J Clin Lab Invest 1974;34:357-361.
19. Beers RF Jr, Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 1952;195:133-144.
20. McCord JM, Fridovich I. The reduction of cytochrome c by milk xantine oxidase. J Biol Chem 1968;243:5753-60.
21. Anderson ME, Powrie F. Puri RM, Meister A. Glutathione monoethylester: preparation, uptake by tissues and conversion to glutathione. Arch Biochem Biophys 1985;239:538-48.
22. Sze G. Kaplowitz N. Ookhtens M, Lu SC. Bidirectional membrane transport of intact glutathione in HepG2 cells. Am J Physiol 1993;28:G1128-34.
23. Ulvik R. Romslo I. Studies on the mobilization of iron from ferritin by isolated rat liver mitochondria. Biochim Biophys Acta 1979;588:256-71.
24. Minotti G. Mancuso C, Frustaci A, Mordente A, Santini SA, Calafiore AM, Liberi G. Gentiloni N. Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin. J Clin Invest 1996;98:650-61.
25. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-10.
26. Rutenburg AM, Kim H. Fischbein JW, Hanker JS, Wasserkrug HL, Seligman AM. Histochemical and ultrastructural demonstration of γ-glutamyl transpeptidase. J Histochem Cytochem 1969;17:517-26.
27. Zhu W, Roma P, Pirillo A, Pellegatta F, Catapano AL. Human endothelial cells exposed to oxidized LDL express hsp70 only when proliferating. Arterioscler Thromb Vasc Biol 1996;16:1104-11.
28. Crichton RR, Ward RJ. Iron metabolism: new perspectives in view. Biochemistry 1992;31:11255-64.
29. Tate SS, Meister A. Gamma-glutamyl transpeptidase from kidney. Methods Enzymol 1985;113:400-19.
30. Stark A-A, Pagano DA, Arad A, Siskindovitch S. Zeiger E. Effect of pH on mutagenesis by thiols in Salmonella typhimurium TA102. Mutat Res 1989;224:89-94.
31. Misra HP. Generation of superoxide free radical during the autoxidation of thiols. J Biol Chem 1974;249:2151-55.
32. Rowley DA, Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of thiol compounds. FEBS Lett 1982;138:33-6.
33. Smith C, Mitchinson MJ, Aruoma OI, Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J 1992;286:901-5.
34. Olsson IL, Breitman TR. Induction of differentiation of the human histiocytic lymphoma cell line U937 by retinoic acid and cyclic adenosine 3′,5′-monophosphate inducing agents. Cancer Res 1982;42:3924-3927.
35. Faulkner L, Aruoma OI, Brickell PM, Davies MJ, Halliwell B. Woolf N. Katz R. Effects of the synthetic antioxidant, probucol, on the U937 monoblastoid cell line. Atherosclerosis 1993;99:1-13.
36. Pichorner H. Metodiewa D, Winterbourn CC. Generation of superoxide and tyrosine peroxide as a result of tyrosyl radical scavenging by glutathione. Arch Biochem Biophys 1995;323:429-437.
37. Schoneich C. Thiyl radicals, perthiyl radicals and oxidative reactions. In: Biothiols in health and disease. Packer L, Cadenas E, eds. Marcel Dekker Publishing Co. New York, 1995:21.
38. Minotti G. Aust SD. Redox-cycling of iron and lipid peroxidation. Lipids 1992;27:219-26.
39. Tribble DL, Gong EL, Leewenburgh C, Heinecke JW, Carlson EL, Verstuyft JG, Epstein CJ. Fatty streak formation in fat-fed mice exppressing human copper-zinc superoxide dismutase. Arterioscler Thromb Vasc Biol 1997;17:1734-40.
40. Michelet F, Gueguen R, Leroy P, Wellman M, Nicolas A, Siest G. Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, bioogical variables and life habits. Clin Chem 1995;41:1509-17.
41. Lu SC, Sun W-M, Yi J, Ookhtens M, Sze G, Kaplowitz N. Role of two recently cloned rat liver GSH transporters in the ubiquitous transport of GSH in mammalian cells. J Clin Invest 1996;97:1488-96.
42. Schulman JD, Goodman SI, Mace JW, Patrick AD, Tietze S, Butler EJ. Glutathionuria: inborn error of metabolism due to tissue deficiency of gamma-glutamyl transpeptidase. Biochem Biophys Res Commun 1975;65:68-74.
43. Griffith OW, Meister A. Translocation of intracellular glutathione to membrane bound gamma-glutamyl transpeptidase as a discrete step in the gamma-glutamyl cycle: glutathionuria after inhibition of the transpeptidase. Proc Nat Acad Sci USA 1979;76:268-79.
44. Grooteld M, Bell J, Halliwell B, Aruoma OI, Bomford A, Sadler PJ. Nontransferrin-bound iron in plasma and serum from patients with idiopathic hemochromatosis. J Biol Chem 1989;264:4417-4422.
45. Meyers DG. The iron hypothesis - does iron cause atherosclerosis? Clin Cardiol 1996;19:925-9.
46. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 1997;96:3300-7.
47. Graham A, Hogg N, Kalyanaraman B, O'Leary V, Darley-Usmar V, Moncada S. Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor. FEBS Lett 1993;330:181-5.
48. Daugherty A, Dunn JL, Rateri DL, Heinecke JW. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 1994;94:437-44.
49. Pang JH, Jiang MJ, Chen YL, Wang FW, Chu SH, Chan LY. Increased ferritin gene expression in atherosclerotic lesions. J Clin Invest 1996;97:2204-12.
50. Nystrom E, Bengtsson C, Lindstedt G. Lapidus L, Lindquist O. Waldenstrom J. Serum gamma-glutamyl transferase in a Swedish female population. Age-related reference intervals; morbidity, and prognosis in cases with raised catalytic concentrations. Acta Med Scand 1988;224:79-84.
51. Betro MG, Oon RC, Edwards JB. Gamma-glutamyl transpeptidase and other liver function tests in myocardial infarction and heart failure. Am J Clin Pathol 1973;60:679-83.
52. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995;142:699-708.